The US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical ...
The proprietary technologies on the Beckman Coulter DxI 9000 Immunoassay Analyzer coupled with its novel Lumi-Phos PRO substrate has enabled development of precise, clinically relevant assays and ...
A broad menu of high quality assays from Beckman Coulter, plus new, productivity-enhancing features on the Access 2 offer laboratories a flexible option for immunoassay testing.
BREA, Calif., March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry ...
Beckman Coulter Diagnostics announced ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu of DxI 9000 ...
The proprietary technologies on the Beckman Coulter DxI 9000 Immunoassay Analyzer coupled with its novel Lumi-Phos PRO substrate has enabled development of precise, clinically relevant assays and ...